Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis.
Int J Trichology, 2023 Introduction: Alopecia totalis (AT) and Alopecia universalis (AU) are forms of Alopecia areata (AA) which represent the strongest predictor of poor prognosis since spontaneous regrowth is <10%. Topical immunotherapy agent, diphenylcyclopropenone (DPCP) has shown clinical efficacy with limited side effects in severe forms of ...
Varghese SA +3 more
europepmc +6 more sources
A case of unusual comedogenesis in alopecia totalis [PDF]
Indian Dermatology Online Journal, 2022 A 19‐year‐old male with a 3‐year history of alopecia totalis came to our department with multiple asymptomatic blackhead‐like lesions all over the bald scalp for 3 months.
Balkrishna P Nikam +3 more
doaj +5 more sources
Effective management Alopecia totalis by Ayurveda – A case report [PDF]
Journal of Ayurveda and Integrative Medicine, 2023 Alopecia areata (AA) is a T-cell-mediated autoimmune illness characterized by intermittent, non-scarring hair loss, Alopecia totalis(AT) is a type of AA characterized by total hair loss on the face and scalp.
Shivanand B. Patil +2 more
doaj +3 more sources
Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review. [PDF]
World J Clin Pediatr, 2021 BACKGROUND: Alopecia areata (AA) is an inflammatory disease with autoimmune, environmental, and inherited components directed at the hair follicle, either limited to patchy hair loss over the scalp (Focalis, AF), total loss of scalp hair (Totalis, AT ...
Papadimitriou DT +4 more
europepmc +3 more sources
The Role of Tofacitinib in the Management of Alopecia Totalis. [PDF]
Sultan Qaboos Univ Med J, 2019 Medical ...
Hernandez-Montoya C, Ruiz-Villaverde R.
europepmc +6 more sources
Nail lichen planus in a patient with alopecia totalis [PDF]
Dermatology Online Journal, 2015 A 67-year-old man with a three-year history of non-scarring alopecia that progressed to alopecia totalis despite intralesional glucocorticoid injections is presented. He developed 20-nail dystrophy that was recalcitrant to antifungal and anti-inflammatory treatments. Biopsy of the nail matrix showed histopathologic features of lichen planus.
Brian Ginsberg +6 more
openalex +6 more sources
Molecular signatures define alopecia areata subtypes and transcriptional biomarkers [PDF]
EBioMedicine, 2016 Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. In this study, we conducted whole genome gene expression analysis of 96 human scalp skin biopsy specimens from AA or normal control subjects.
Ali Jabbari +9 more
doaj +3 more sources
Hepatitis C Treatment and Alopecia Totalis [PDF]
Journal of Investigative Dermatology Symposium Proceedings, 2013 Peg-interferon alpha-2a and 2b and ribavirin have become the mainstays of chronic hepatitis C treatment. Although various cutaneous side effects have been reported, alopecia areata in its various forms have rare reports and has not been well categorized.
Carolyn Goh
openalex +3 more sources
Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark [PDF]
Acta Dermato-VenereologicaThe emergence of new systemic treatments for alopecia areata underscores the importance of estimating rates of potential treatment safety events among individuals with alopecia areata.
Sissel Brandt Toft Sørensen +7 more
doaj +2 more sources
Alopecia totalis and vitiligo in common variable immunodeficiency [PDF]
Postgraduate Medical Journal, 1991 Summary Three cases of severe and irreversible alopecia occurring in patients with common variable immunodeficiency are described. In all three cases, hair loss developed after the diagnosis of immune deficiency; one of the patients also had extensive vitiligo. A fourth patient had vitiligo in the absence of alopecia.
G Spickett +4 more
openalex +6 more sources